J 2021

Electrophysiological biomarkers for deep brain stimulation outcomes in movement disorders: state of the art and future challenges

BOČKOVÁ, Martina and Ivan REKTOR

Basic information

Original name

Electrophysiological biomarkers for deep brain stimulation outcomes in movement disorders: state of the art and future challenges

Authors

BOČKOVÁ, Martina (203 Czech Republic, belonging to the institution) and Ivan REKTOR (203 Czech Republic, guarantor, belonging to the institution)

Edition

Journal of Neural Transmission, WIEN, SPRINGER WIEN, 2021, 0300-9564

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30210 Clinical neurology

Country of publisher

Austria

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 3.850

RIV identification code

RIV/00216224:14740/21:00119422

Organization unit

Central European Institute of Technology

UT WoS

000671636200001

Keywords in English

Deep brain stimulation; EEG biomarkers; Local field potentials; Movement disorders

Tags

International impact, Reviewed
Změněno: 14/12/2021 10:02, Mgr. Pavla Foltynová, Ph.D.

Abstract

V originále

Several neurological diseases are accompanied by rhythmic oscillatory dysfunctions in various frequency ranges and disturbed cross-frequency relationships on regional, interregional, and whole brain levels. Knowledge of these disease-specific oscillopathies is important mainly in the context of deep brain stimulation (DBS) therapy. Electrophysiological biomarkers have been used as input signals for adaptive DBS (aDBS) as well as preoperative outcome predictors. As movement disorders, particularly Parkinson's disease (PD), are among the most frequent DBS indications, the current research of DBS is the most advanced in the movement disorders field. We reviewed the literature published mainly between 2010 and 2020 to identify the most important findings concerning the current evolution of electrophysiological biomarkers in DBS and to address future challenges for prospective research.

Links

GA21-25953S, research and development project
Name: Subkortikální jádra a kortikální funkce z perspektivy hluboké mozkové stimulace (Acronym: DBS3D)
Investor: Czech Science Foundation, Subcortical nuclei and cortical functions – insight from the deep brain stimulation perspective
NU21-04-00445, research and development project
Name: Klinická odpovídavost na STN-DBS u Parkinsonovy nemoci: vliv vaskulárních, kardiovaskulárních, metabolických a zánětlivých komorbidit (Acronym: DBScomorbidities)
Investor: Ministry of Health of the CR, STN-DBS outcomes in Parkinson´s disease: the influence of vascular, cardiovascular, metabolic, and inflammatory co-morbidities., Subprogram 1 - standard